Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

J.&J.’s Next Chief Is Steeped in Sales Culture
NY Times, NY
Friday, February 24, 2012 - 9:50am
tags:
JNJ, Pharma CEOs, Alex Gorsky
FDA panel recommends Chelsea Therapeutics drug
Reuters
Thursday, February 23, 2012 - 5:49pm
tags:
FDA, advisory panels, Chelsea Therapeutics, Northera
U.S. panel backs Forest Labs drug for smoker's cough
Reuters
Thursday, February 23, 2012 - 5:45pm
tags:
Forest Labs, COPD, Almirall, aclidinium bromide
An Overview Of 4 Drug Manufacturers Yielding Over 4%
Seeking Alpha
Thursday, February 23, 2012 - 5:43pm
tags:
Eli Lilly, Merck, Pfizer, Bristol-Myers Squibb
Drug Companies Feel Price Pressure
NY Times, NY
Thursday, February 23, 2012 - 5:43pm
tags:
drug pricing
J&J Recall: Manufacturing issues believed behind CEO departure
Fierce Pharma Manufacturing
Thursday, February 23, 2012 - 12:04pm
tags:
recalls, JNJ, William Weldon, Pharma CEOs
MannKind Narrows Loss
Yahoo/Zacks
Thursday, February 23, 2012 - 11:59am
tags:
earnings, MannKind
The Battle For The Anti-Coagulation Market
Seeking Alpha
Thursday, February 23, 2012 - 11:58am
tags:
anticoagulants, Pfizer, Sanofi, Bristol-Myers Squibb
Chelsea Therapeutics: FDA Panel Live Blog
TheStreet.com
Thursday, February 23, 2012 - 10:43am
tags:
FDA, advisory panels, Chelsea Therapeutics, Northera
4 Compelling Alternatives To Vertex Pharma
Seeking Alpha
Thursday, February 23, 2012 - 10:42am
tags:
Vertex Pharmaceuticals, Acorda, Aveo Pharmaceutical, Jazz Pharmaceuticals, Momenta
Vivus rockets 99% on FDA nod
Marketwatch
Thursday, February 23, 2012 - 10:41am
tags:
FDA, Vivus, obesity, Qnexa
Satori snags $15M to fuel a trial on Alzheimer's drug
Fierce Biotech
Thursday, February 23, 2012 - 10:40am
tags:
Satori, Alzheimer's disease, amyloid beta
Novartis Urged To Drop Gleevec Patent Case
Pharmalot
Thursday, February 23, 2012 - 10:38am
tags:
Gleevac, Novartis, patents
Par Pharma Absorbs Edict Pharma
Yahoo/Zacks
Thursday, February 23, 2012 - 10:37am
tags:
Edict Pharmaceuticals, Par Pharmaceutical
Medicines Co 4Q profit slides, trumps expectations
Yahoo/AP
Thursday, February 23, 2012 - 10:36am
tags:
earnings, Medicines Company
Paladin and Somaxon Announce Filing of New Drug Submission for Silenor
Yahoo
Thursday, February 23, 2012 - 10:36am
tags:
Paladin, Somaxon, Silenor, Canada, insomnia
MAP Pharmaceuticals Issued Additional U.S. Patent for Methods of Achieving Rapid Treatment of Migraine Based Upon Pharmacokinetic Profile
Yahoo
Thursday, February 23, 2012 - 10:35am
tags:
migraines, MAP Pharmaceuticals, patents
Johnson & Johnson CEO is Out, but not Gone
TheStreet.com
Thursday, February 23, 2012 - 10:34am
tags:
William Weldon, Pharma CEOs, JNJ
Ranbaxy Reports $606 Million Loss After U.S. Settlement
Bloomberg
Thursday, February 23, 2012 - 10:33am
tags:
Ranbaxy, earnings
FDA panel overwhelmingly backs previously rejected anti-obesity pill Qnexa
Washington Post, DC
Wednesday, February 22, 2012 - 10:12pm
tags:
FDA, Vivus, obesity, Qnexa, advisory panel

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.